Literature DB >> 6793402

A kirromycin resistant elongation factor EF-Tu from Escherichia coli contains a threonine instead of an alanine residue in position 375.

F J Duisterwinkel, J M de Graaf, B Kraal, L Bosch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6793402     DOI： 10.1016/0014-5793(81)80894-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  10 in total

1.  Complete nucleotide sequences of seven eubacterial genes coding for the elongation factor Tu: functional, structural and phylogenetic evaluations.

Authors:  W Ludwig; M Weizenegger; D Betzl; E Leidel; T Lenz; A Ludvigsen; D Möllenhoff; P Wenzig; K H Schleifer
Journal:  Arch Microbiol       Date:  1990       Impact factor: 2.552

2.  A signal relay between ribosomal protein S12 and elongation factor EF-Tu during decoding of mRNA.

Authors:  Steven T Gregory; Jennifer F Carr; Albert E Dahlberg
Journal:  RNA       Date:  2008-12-17       Impact factor: 4.942

3.  Mutant ribosomes can generate dominant kirromycin resistance.

Authors:  I Tubulekas; R H Buckingham; D Hughes
Journal:  J Bacteriol       Date:  1991-06       Impact factor: 3.490

4.  The influence of different modifications of elongation factor Tu from Escherichia coli on ternary complex formation investigated by fluorescence spectroscopy.

Authors:  G Ott; J Jonák; I P Abrahams; M Sprinzl
Journal:  Nucleic Acids Res       Date:  1990-02-11       Impact factor: 16.971

5.  Molecular properties of elongation factor Tu from Streptomyces aureofaciens and Escherichia coli.

Authors:  J Weiser; P Sebo
Journal:  Folia Microbiol (Praha)       Date:  1988       Impact factor: 2.099

6.  Effects of elfamycins on elongation factor Tu from Escherichia coli and Staphylococcus aureus.

Authors:  C C Hall; J D Watkins; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

7.  Differential susceptibilities of enterococcal species to elfamycin antibiotics.

Authors:  A Miele; B P Goldstein; M Bandera; C Jarvis; A Resconi; R J Williams
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

8.  The structural and functional basis for the kirromycin resistance of mutant EF-Tu species in Escherichia coli.

Authors:  J R Mesters; L A Zeef; R Hilgenfeld; J M de Graaf; B Kraal; L Bosch
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

9.  The elongation factor Tu.kirromycin complex has two binding sites for tRNA molecules.

Authors:  J M van Noort; F J Duisterwinkel; J Jonák; J Sedlácek; B Kraal; L Bosch
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

10.  Specific alterations of the EF-Tu polypeptide chain considered in the light of its three-dimensional structure.

Authors:  F J Duisterwinkel; B Kraal; J M De Graaf; A Talens; L Bosch; G W Swart; A Parmeggiani; T F La Cour; J Nyborg; B F Clark
Journal:  EMBO J       Date:  1984-01       Impact factor: 11.598
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.